Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

Cancer. 2014 Jun 1;120(11):1604-7. doi: 10.1002/cncr.28636. Epub 2014 Feb 27.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Ramucirumab
  • Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Protein Kinase Inhibitors
  • Vascular Endothelial Growth Factor Receptor-2